Skip to main content
VCbacked
Log inGet Started

Rakuten Medical

San Diego, United States

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.

$100.0M raised
Apr 2026
Venture - Series Unknown
BiotechnologyHealth CareMedicalService IndustryTherapeutics

Top Investors

General CatalystMizuho BankRakutenSumitomo Mitsui Banking CorporationSBI Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rakuten Medical

How much funding has Rakuten Medical raised?
Rakuten Medical has raised $100.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Rakuten Medical's investors?
Rakuten Medical's investors include General Catalyst, Mizuho Bank, Rakuten, Sumitomo Mitsui Banking Corporation, SBI Group.
Where is Rakuten Medical headquartered?
Rakuten Medical is headquartered in San Diego, United States.
What does Rakuten Medical do?
Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.
What stage is Rakuten Medical at?
Rakuten Medical is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rakuten Medical — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/rakuten-medical. Accessed June 3, 2026.
APA
VCBacked. (2026). Rakuten Medical — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/rakuten-medical
Wikipedia (cite web)
{{cite web |title=Rakuten Medical — Funding & Investors |url=https://www.vcbacked.co/company/rakuten-medical |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong